129 related articles for article (PubMed ID: 10843452)
1. Telomerase activity in urine after transurethral resection of superficial bladder cancer and early recurrence.
Wu XX; Kakehi Y; Takahashi T; Habuchi T; Ogawa O
Int J Urol; 2000 Jun; 7(6):210-7. PubMed ID: 10843452
[TBL] [Abstract][Full Text] [Related]
2. Subsequential telomerase activity in exfoliated urinary cells detects recurrent disease in bladder cancer after transurethral resection.
Kitsukawa SI; Ohyashiki K; Yahata N; Ebihara Y; Aizawa T; Ito T; Miki M
Int J Oncol; 1999 Sep; 15(3):505-10. PubMed ID: 10427132
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine.
Descotes F; Kara N; Decaussin-Petrucci M; Piaton E; Geiguer F; Rodriguez-Lafrasse C; Terrier JE; Lopez J; Ruffion A
Br J Cancer; 2017 Aug; 117(4):583-587. PubMed ID: 28683471
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity in urine after transurethral resection is not a predictive marker for recurrence of superficial bladder cancer.
Wu XX; Kakehi Y; Nishiyama H; Habuchi T; Ogawa O
Int J Urol; 2003 Feb; 10(2):117-8. PubMed ID: 12588612
[No Abstract] [Full Text] [Related]
5. FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.
Beukers W; van der Keur KA; Kandimalla R; Vergouwe Y; Steyerberg EW; Boormans JL; Jensen JB; Lorente JA; Real FX; Segersten U; Orntoft TF; Malats N; Malmström PU; Dyrskjot L; Zwarthoff EC
J Urol; 2017 Jun; 197(6):1410-1418. PubMed ID: 28049011
[TBL] [Abstract][Full Text] [Related]
6. Pre and postoperative quantitative detection of fragments of cytokeratins 8 and 18 (UBC IRMA) as markers of early recurrence of superficial bladder tumor.
Gacci M; Serni S; Lapini A; Giubilei G; Dal Canto M; Paladini S; Curotto A; Gallo F; Carmignani G; Carini M
Arch Ital Urol Androl; 2006 Mar; 78(1):5-10. PubMed ID: 16752880
[TBL] [Abstract][Full Text] [Related]
7. Limited significance of routine excretory urography in the follow-up of patients with superficial bladder cancer after transurethral resection.
Miyake H; Hara I; Yamanaka K; Inoue TA; Fujisawa M
BJU Int; 2006 Apr; 97(4):720-3. PubMed ID: 16536761
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.
Schulze M; Stotz N; Rassweiler J
J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695
[TBL] [Abstract][Full Text] [Related]
9. The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study.
Couffignal C; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Mentre F; Cussenot O; Grandchamp B
Urology; 2015 Dec; 86(6):1185-90. PubMed ID: 26364695
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
[TBL] [Abstract][Full Text] [Related]
11. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
Kavaler E; Landman J; Chang Y; Droller MJ; Liu BC
Cancer; 1998 Feb; 82(4):708-14. PubMed ID: 9477104
[TBL] [Abstract][Full Text] [Related]
12. Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer.
Eissa S; Labib RA; Mourad MS; Kamel K; El-Ahmady O
Eur Urol; 2003 Dec; 44(6):687-94. PubMed ID: 14644121
[TBL] [Abstract][Full Text] [Related]
13. [Telomerase activity as marker of superficial tumor of the bladder].
Arias Fúnez F; Fernández Fernández E; Escudero Barrilero A; Moyano Jato A; Caso Peláez E
Arch Esp Urol; 2000 Apr; 53(3):231-6. PubMed ID: 10851728
[TBL] [Abstract][Full Text] [Related]
14. Relevance of urine telomerase in the diagnosis of bladder cancer.
Sanchini MA; Gunelli R; Nanni O; Bravaccini S; Fabbri C; Sermasi A; Bercovich E; Ravaioli A; Amadori D; Calistri D
JAMA; 2005 Oct; 294(16):2052-6. PubMed ID: 16249419
[TBL] [Abstract][Full Text] [Related]
15. [Urinary cytology studied during 10 days after transurethral resection of bladder tumour and its relation to tumour recurrence].
Iguchi A; Yoshinaga H; Masaki Z; Tsugitomi H; Wakayama K
Nihon Hinyokika Gakkai Zasshi; 1991 Sep; 82(9):1430-5. PubMed ID: 1942702
[TBL] [Abstract][Full Text] [Related]
16. [The significance of urine cytology three consecutive days after transurethral resection as a predictor of superficial bladder cancer recurrence].
Yumura Y; Takase K; Kato Y; Hamano A; Mikata K; Ogo Y; Noguchi S; Satomi Y
Hinyokika Kiyo; 2004 Mar; 50(3):171-6. PubMed ID: 15148768
[TBL] [Abstract][Full Text] [Related]
17. Repeated transurethral resection and intravesical BCG for extensive superficial bladder tumors.
Ozen H; Ekici S; Uygur MC; Akbal C; Sahin A
J Endourol; 2001 Oct; 15(8):863-7. PubMed ID: 11724131
[TBL] [Abstract][Full Text] [Related]
18. A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results.
Poulakis V; Witzsch U; De Vries R; Altmannsberger HM; Manyak MJ; Becht E
BJU Int; 2001 Nov; 88(7):692-701. PubMed ID: 11890239
[TBL] [Abstract][Full Text] [Related]
19. [Clinical experience with transurethral resection of bladder tumor (TUR-Bt) guided by photodynamic diagnosis (PDD)].
Inoue K; Kuno T; Fukuhara H; Hamaguchi T; Fukata S; Karashima T; Kamada M; Shuin T; Sakakura N; Kasahara K; Watanabe H; Kozai T; Yasuda M; Kataoka S; Tanimura M; Atsushi K; Furihata M
Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):661-70. PubMed ID: 19999130
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in urine in diagnosis and recurrence surveillance of urothelial carcinoma.
Li Z; Kong C; Wang P; Liu X; Liu T
Chin Med J (Engl); 2002 Nov; 115(11):1650-2. PubMed ID: 12609080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]